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SCIENTIFIC OPINION 
Scientific Opinion on the substantiation of a health claim related to glucose 
and contribution to energy-yielding metabolism pursuant to Article 13(5) 
of Regulation (EC) No 1924/2006
1
 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2, 3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following an application from Dextro Energy GmbH & Co. KG, submitted pursuant to Article 13(5) of 
Regulation (EC) No 1924/2006 via the Competent Authority of Germany, the Panel on Dietetic Products, 
Nutrition and Allergies was asked to deliver an opinion on the scientific substantiation of a health claim related to 
glucose and “contributes to normal muscle function”. The scope of the application was proposed to fall under a 
health claim based on newly developed scientific evidence. The food constituent that is the subject of the health 
claim is glucose, which is sufficiently characterised. The claimed effect is “contributes to normal muscle 
function”. The proposed target population is healthy, active, as well as endurance trained, men and women. The 
Panel notes that the claimed effect refers to the contribution of the food constituent to energy-yielding 
metabolism in active individuals. Energy-yielding metabolism is needed for all functions of the body, including 
normal muscle function. The Panel considers that contribution to energy-yielding metabolism is a beneficial 
physiological effect. A claim on glucose and contribution to energy-yielding metabolism has already been 
assessed with a favourable outcome. © European Food Safety Authority, 2012 
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SUMMARY 
Following an application from Dextro Energy GmbH & Co. KG, submitted pursuant to Article 13(5) 
of Regulation (EC) No 1924/2006 via the Competent Authority of Germany, the Panel on Dietetic 
Products, Nutrition and Allergies was asked to deliver an opinion on the scientific substantiation of a 
health claim related to glucose and “contributes to normal muscle function”. 
The scope of the application was proposed to fall under a health claim based on newly developed 
scientific evidence. 
The food constituent that is the subject of the health claim is glucose. Glucose can be consumed in the 
diet as a monosaccharide or be obtained from disaccharides, oligosaccharides and polysaccharides, 
which are digested and absorbed in the human small intestine and provide glucose to body cells as a 
source of energy. Besides glucose itself, the main glycaemic carbohydrates providing glucose in the 
diet are sucrose and lactose (disaccharides), as well as malto-oligosaccharides and starch 
(polysaccharides). This evaluation refers to glucose from all dietary sources. The Panel considers that 
the food constituent, glucose, which is the subject of the health claim, is sufficiently characterised.  
The claimed effect is “contributes to normal muscle function”. The target population proposed by the 
applicant is healthy, active, as well as endurance trained, men and women. In the context of the 
information provided, and in the context of the clarifications provided by the applicant during the 
validation of this application, the Panel notes that the claimed effect refers to the contribution of the 
food constituent to energy-yielding metabolism in active individuals. Energy-yielding metabolism is 
needed for all functions of the body, including normal muscle function. The Panel considers that 
contribution to energy-yielding metabolism is a beneficial physiological effect. 
A claim on glucose and contribution to energy-yielding metabolism has already been assessed with a 
favourable outcome.  
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BACKGROUND 
Regulation (EC) No 1924/2006
4
 harmonises the provisions that relate to nutrition and health claims, 
and establishes rules governing the Community authorisation of health claims made on foods. As a 
rule, health claims are prohibited unless they comply with the general and specific requirements of 
this Regulation, are authorised in accordance with this Regulation, and are included in the lists of 
authorised claims provided for in Articles 13 and 14 thereof. In particular, Article 13(5) of this 
Regulation lays down provisions for the addition of claims (other than those referring to the reduction 
of disease risk and to children’s development and health) which are based on newly developed 
scientific evidence, or which include a request for the protection of proprietary data, to the 
Community list of permitted claims referred to in Article 13(3). 
According to Article 18 of this Regulation, an application for inclusion in the Community list of 
permitted claims referred to in Art 13(3) shall be submitted by the applicant to the national competent 
authority of a Member State, which will make the application and any supplementary information 
supplied by the applicant available to the European Food Safety Authority (EFSA). 
STEPS TAKEN BY EFSA 
 The application was received on 27/01/2012. 
 The scope of the application was proposed to fall under a health claim based on newly 
developed scientific evidence. 
 On 12/03/2012, during the validation process of the application, EFSA sent a request to the 
applicant to provide clarifications/missing information. 
 The applicant provided the clarifications/missing information on 29/03/2012. 
 The scientific evaluation procedure started on 30/03/2012. 
 During its meeting on 25/04/2012, the NDA Panel, having evaluated the data submitted, 
adopted an opinion on the scientific substantiation of a health claim related to glucose and 
contribution to energy-yielding metabolism. 
TERMS OF REFERENCE 
EFSA is requested to evaluate the scientific data submitted by the applicant in accordance with 
Article 16(3) of Regulation (EC) No 1924/2006. On the basis of that evaluation, EFSA will issue an 
opinion on the scientific substantiation of a health claim related to: glucose and “contributes to 
normal muscle function”. 
EFSA DISCLAIMER 
The present opinion does not constitute, and cannot be construed as, an authorisation for the 
marketing of glucose, a positive assessment of its safety, nor a decision on whether glucose is, or is 
not, classified as a foodstuff. It should be noted that such an assessment is not foreseen in the 
framework of Regulation (EC) No 1924/2006. 
It should also be highlighted that the scope, the proposed wording of the claim, and the conditions of 
use as proposed by the applicant may be subject to changes, pending the outcome of the authorisation 
procedure foreseen in Article 18(4) of Regulation (EC) No 1924/2006. 
                                                     
4 Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and 
health claims made on foods. OJ L 404, 30.12.2006, p. 9–25. 
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INFORMATION PROVIDED BY THE APPLICANT 
Applicant’s name and address: Dextro Energy GmbH & Co. KG. Hafenstrasse 77, 47809, Krefeld. 
Germany. 
Food/constituent as stated by the applicant 
According to the applicant, glucose (synonymous dextrose), C6H12O6, M=180.16 g/mol 
Health relationship as claimed by the applicant 
According to the applicant, “during exercise muscle glycogen and blood glucose as well as exogen 
glucose are major substrates for oxidative metabolism, generation of adenosine triphosphate (ATP) 
and thus muscle activity. Muscle glycogen has to be broken down into glucose monomers. 
Carbohydrates present in limited amounts in muscle (300 g glycogen), liver (90 g glycogen) and body 
fluids (30 g glycogen) are a major fuel for physical performance. The ATP stored in muscle cells can 
only give high-power output for a few seconds. If the maximum effort lasts for 30 seconds or longer, 
then breakdown of muscle glycogen and subsequent degradation within glycolysis, citrate cycle and 
respiratory chain can supply the energy by producing ATP. Most physical activity requires an energy 
source that can power muscles for longer periods. In conclusion ingestion of glucose during physical 
activity can increase the amount of metabolic energy for skeletal muscle and associated extend time to 
exhaustion. Thus it is a beneficial physiological effect because glucose is needed for normal muscle 
metabolism, whereby it supports adequate energy supply during exercise. Therefore, total as well as 
endogenous and exogenous glucose respectively carbohydrate oxidation is used to assess the claimed 
effect. Numerous studies have shown significant relationships between glucose ingestion and the 
oxidation of glucose (total, endogenous and exogenous oxidation). For example one study showed 
significantly higher rates of total carbohydrate oxidation rates during exercise after glucose and 
maltodextrin ingestion (0.7 g/kg body mass) compared to placebo (2.35+/-0.37 vs. 1.97+/-0.33 g/min; 
p<0.001). During exercise the carbohydrate oxidation rates were significantly higher (p<0.05) by 
ingestion of similar quantities of glucose (1 g/kg body mass) compared to placebo (2.34+/-0.09 vs. 
2.11+/-0.09 g/min). Furthermore, former studies have shown that glucose ingestion (200 g) during 
exercise results in augmented uptake and oxidation of glucose by the exercising muscle compared to 
placebo. Finally glucose feedings (120 g) upon exercise leads to 0.53 g/min greater rate of 
carbohydrate utilization than during placebo trial. It should be noted that factors such as the 
carbohydrate content of the habitual diet or intake during training sessions may play a role in 
determine capacity of oxidizing carbohydrate ingested during exercise”. 
Description of the mechanism(s) by which the food/constituent exerts the claimed effect as 
proposed by the applicant 
According to the applicant, “the claimed effect was thoroughly examined in scientific analysis and 
studies and is well established in scientific literature. Furthermore, the mechanism by which glucose 
exerts the claimed effect is described below. 
Glucose is a major source of metabolic energy for most body cells including the brain which requires 
glucose for its energy needs. Glucose is ingested in form of monosaccharides or in form of 
polysaccharides, mainly starch, which has to be broken down into its constituent monosaccharide 
glucose before absorption. The membranes of human cells which contain a high level of lipids are 
relatively impermeable to hydrophylic polar molecules such as glucose. The entry and exit of glucose 
are mediated by specific transport processes. Carrier proteins located in the plasma membranes of 
cells can bind glucose and facilitate their traverse through the lipid membrane barrier, thus releasing 
the hexose into the cellular cytoplasm (e.g. skeletal muscle) or body fluids (e.g. blood). The Insulin-
Responsive Glucose Transporter is the major glucose transporter of the insulin-sensitive tissues, 
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brown and white fat, and skeletal and cardiac muscle. Insulin stimulation causes a rapid increase in 
the number of glucose transporters on the membrane and then fuse with it, releasing the molecule. 
This process ensures a high density of glucose transporters and enhances the ability to move glucose 
from the surrounding cellular fluid into the interior of the cell especially during physical activity.  
Glucose is stored in liver and muscle as the branched polymer glycogen. Although it occurs in 
concentrations of up to 6 % of liver mass but only 1 % of muscle, muscle mass is so much greater that 
it represents three to four times as much glycogen as stored in the liver. Muscle glycogen is mainly 
used by the muscle, but liver glycogen is for storage, hydrolysis and export as glucose, and the 
maintenance of blood glucose concentrations. Carbohydrates present in limited amounts in muscle 
(300 g glycogen), liver (90 g glycogen) and body fluids (30 g glycogen) are a major fuel for physical 
performance. The ATP stored in muscle cells can only give high-power output for a few seconds. If 
the maximum effort lasts for 30 seconds or longer, then breakdown of muscle glycogen and 
subsequent degradation within glycolysis, citrate cycle and respiratory chain can supply the energy by 
producing ATP. Most physical activity requires an energy source that can power muscles for longer 
periods than the body’s own stores can deliver.  
Both duration and intensity of exercise determine the mix of fuel used. At light to moderate activity 
levels (45% VO2 max), as duration of exercise lengthens, the contribution of fat to energy production 
increases. In contrast, as the intensity of activity increases from rest to light to moderate to intense 
(45 % VO2 max, 65 % VO2 max, 845 % VO2 max), the contribution of carbohydrates to energy production 
increases. Ultimately, the amount of carbohydrates stored in the body (muscle, liver, body fluids) sets 
the limits for continued performance, and fatigue arises when the glycogen stores become depleted. 
The stores of carbohydrates usually suffice for just 1 to 3 hours of physical exertion, depending on the 
intensity of effort. Muscle glycogen use increases after 90 min exercise after consumption of glucose 
solution (6.4 % glucose in 8 ml solution/kg body mass) compared to placebo (4.2+/-2.8 mmol/kg dry 
mass*min vs. 2.5+/-0.7 mmol/kg dry mass*min; p=0.1). Ingestion of glucose increases glucose uptake 
when it is taken during prolonged, strenuous exercise and does not appear to limit physical 
performance. In conclusion ingestion of glucose contributes to normal muscle function. Thus it is a 
beneficial physiological effect because glucose is needed for normal muscle metabolism, whereby it 
supports adequate energy supply during exercise”. 
Wording of the health claim as proposed by the applicant 
The applicant has proposed the following wording for the health claim: “glucose contributes to 
normal muscle function”. 
Specific conditions of use as proposed by the applicant 
As proposed by the applicant, “the target population for consumption of glucose which contributes to 
muscle function are healthy active as well as well and endurance trained men and women”. 
According to the applicant, “the quantity of glucose required to obtain the claimed effect is less than 
30 g/h (0.5 g/min) for sports lasting 1 h, 30-60 g/h (0.5-1.0 g/min) for sports of longer duration and 
90 g/h (1.5 g/min) for events >2.5 h. 50-75 g ingestion as a single bolus is effective as well. 
Prolonging the rate of glucose absorption enhances insulin economy and glucose disposal. A study 
showed that a mild rebound hypoglycaemia following pre-exercise glucose ingestion does not affect 
performance. Altering the timing of the ingestion (15, 45 or 75 min before exercise) resulted in 
differences in plasma glucose/insulin responses which disappeared within 10 min of exercise and 
which had no effect on performance. Ingestion of carbohydrates in the form of a solid bar resulted in 
similar mean and peak exogenous carbohydrate oxidation rates and showed similar oxidation 
efficiency as an isocarbohydrated drink. It should be noted that factors such as the carbohydrate 
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content of the habitual diet or intake during training sessions may play a role in determine capacity of 
oxidizing carbohydrates ingested during physical activity”. 
ASSESSMENT 
1. Characterisation of the food/constituent 
The food constituent that is the subject of the health claim is glucose.  
Glucose can be consumed in the diet as a monosaccharide or be obtained from disaccharides, 
oligosaccharides and polysaccharides, which are digested and absorbed in the human small intestine 
and provide glucose to body cells as a source of energy. Besides glucose itself, the main glycaemic 
carbohydrates providing glucose in the diet are sucrose and lactose (disaccharides), as well as malto-
oligosaccharides and starch (polysaccharides) (EFSA Panel on Dietetic Products Nutrition and 
Allergies (NDA), 2010; FAO/WHO, 1998).  
This evaluation refers to glucose from all dietary sources. 
The Panel considers that the food constituent, glucose, which is the subject of the health claim, is 
sufficiently characterised. 
2. Relevance of the claimed effect to human health 
The claimed effect is “contributes to normal muscle function”. The target population proposed by the 
applicant is healthy, active, as well as endurance trained, men and women. 
In the context of the information provided, and in the context of the clarifications provided by the 
applicant during the validation of this application, the Panel notes that the claimed effect refers to the 
contribution of the food constituent to energy-yielding metabolism in active individuals. Normal 
energy-yielding metabolism is needed for all functions of the body, including normal muscle function.  
The Panel considers that contribution to energy-yielding metabolism is a beneficial physiological 
effect. 
3. Scientific substantiation of the claimed effect 
A claim on glucose and contribution to energy-yielding metabolism has already been assessed by the 
Panel with a favourable outcome (EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 
2012).  
The references provided by the applicant as being pertinent to the scientific substantiation of this 
claim were the same as in the previous submission which led to the favourable evaluation indicated 
above.  
CONCLUSIONS 
On the basis of the data presented, the Panel concludes that: 
 The food constituent, glucose, which is the subject of the health claim, is sufficiently 
characterised. 
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 The claimed effect is “contributes to normal muscle function”. The proposed target 
population is healthy, active, as well as endurance trained, men and women. Contribution to 
energy-yielding metabolism is a beneficial physiological effect. 
 A claim on glucose and contribution to energy-yielding metabolism has already been assessed 
with a favourable outcome. 
DOCUMENTATION PROVIDED TO EFSA 
Health claim application on glucose and contribution to energy-yielding metabolism pursuant to 
Article 13(5) of Regulation (EC) No 1924/2006 (Claim serial No: 0326_DE). March 2012. Submitted 
by Dextro Energy GmbH & Co. KG. 
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GLOSSARY/ABBREVIATIONS 
ATP Adenosine Triphosphate 
